Literature DB >> 12641422

The association of health-care use and hepatitis C virus infection in a random sample of urban slum community residents in southern India.

Melissa A Marx1, K G Murugavel, Sudha Sivaram, P Balakrishnan, Mark Steinhoff, S Anand, David L Thomas, Suniti Solomon, David D Celentano.   

Abstract

To determine whether health-care use was associated with prevalent hepatitis C virus (HCV) infection in Chennai, India, 1,947 adults from 30 slum communities were randomly selected to be interviewed about parenteral and sexual risks for HCV infection and to provide biological specimens for HCV and sexually transmitted infection (STI) testing. Prevalent HCV infection was detected in 2.4% of non-injection drug using (IDU) participants. Controlling for other associated factors, and excluding IDU, men who used informal health-care providers were five times as likely to be HCV infected as those who did not use informal providers (Adjusted Odds Ratio, AOR = 5.83; 95% confidence interval [CI]: 1.57, 21.6), a finding not detected in women. More research is needed to determine the extent to which HCV infection is associated with reuse of contaminated injection equipment in health-care settings in developing countries.

Entities:  

Mesh:

Year:  2003        PMID: 12641422

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

1.  Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.

Authors:  Doa'a A Saleh; Fatma Shebl; Mohamed Abdel-Hamid; Shaker Narooz; Nabiel Mikhail; Manal El-Batanony; Sherif El-Kafrawy; Mai El-Daly; Soraya Sharaf; Mohamed Hashem; Samer El-Kamary; Laurence S Magder; Sonia K Stoszek; G Thomas Strickland
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-06-02       Impact factor: 2.184

Review 2.  Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.

Authors:  Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

3.  Case control study to identify risk factors for acute hepatitis C virus infection in Egypt.

Authors:  Amr M Kandeel; Maha Talaat; Salma A Afifi; Nasr M El-Sayed; Moustafa A Abdel Fadeel; Rana A Hajjeh; Frank J Mahoney
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

4.  A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh.

Authors:  A K Azad Chowdhury; Tapash Roy; A B M Faroque; Sitesh C Bachar; Muhammad Asaduzzaman; Nishat Nasrin; Nahid Akter; Hamidur Rahman Gazi; Abul Kalam Lutful Kabir; Masuma Parvin; Claire Anderson
Journal:  BMC Public Health       Date:  2011-10-10       Impact factor: 3.295

5.  Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.

Authors:  Savanna Reid
Journal:  Indian J Community Med       Date:  2012-04

6.  Parenteral medication prescriptions, dispensing and administration habits in Mongolia.

Authors:  Gereltuya Dorj; Bruce Sunderland; Delia Hendrie; Richard Parsons
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

7.  Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India.

Authors:  Javier A Cepeda; Sunil S Solomon; Aylur K Srikrishnan; Paneerselvam Nandagopal; Pachamuthu Balakrishnan; Muniratnam S Kumar; David L Thomas; Mark S Sulkowski; Shruti H Mehta
Journal:  Open Forum Infect Dis       Date:  2016-07-23       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.